H-ASP-PNA HCl, with the CAS number 154564-03-1, is a chemical compound that belongs to the class of peptide nucleic acids (PNAs). PNAs are synthetic analogs of DNA or RNA that have a peptide-like backbone, which allows them to bind to complementary nucleic acid sequences with high specificity and affinity. This particular compound is characterized by its ability to form stable duplexes with DNA or RNA, making it useful in various applications such as molecular diagnostics, gene regulation, and antisense therapy. The hydrochloride (HCl) form indicates that the compound is provided as a salt, which can enhance its solubility in aqueous solutions. H-ASP-PNA HCl is typically utilized in research settings, particularly in studies involving gene expression and the development of novel therapeutic strategies. Its unique properties, including resistance to enzymatic degradation and the ability to hybridize with nucleic acids, make it a valuable tool in the field of molecular biology and genetic engineering.

H-ASP-PNA HCL

154564-03-1: L-Aspartic Acid P-Nitroanilide Hydrochloride, L-Aspartic Acid Alpha-4-Nitroanilide

(S)-3-amino-4-((4-nitrophenyl)amino)-4-oxobutanoic acid hydrochloride

Substrate for isoasparaginases (α-aspartyl dipeptidasess, peptidase E). Asp-pNA is cleaved by St-PepA, a Streptococcus thermophilus aminopeptidase with high specificity for acidic residues, Km 0.42 mM.

H-Asp-pNA · HCl

H-Asp-pNA·HCl is a versatile building block that can be used in the synthesis of complex compounds. It has been shown to be useful in the synthesis of reagents and speciality chemicals, as well as being a reaction component for the synthesis of pharmaceuticals. H-Asp-pNA·HCl is also a useful scaffold for the production of high quality and highly pure products.

CAS 154564-03-1: H-ASP-PNA HCL

(S)-3-amino-4-((4-nitrophenyl)amino)-4-oxobutanoic acid hydrochloride

Ref: 10-F733544

H-Asp-pNA · HCl

Ref: 01-4007367

H-ASP-PNA HCL

Ref: IN-DA00AKU3

H-Asp-pNA·HCl

Ref: 3D-FA110752

L-Aspartic acid α-4-nitroanilide

Ref: 7W-GM9279